Comments on: Organon Allegedly Covered Up Raplon Side Effects http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/ News, Comment and Conversation Fri, 10 Feb 2012 17:56:03 +0000 http://wordpress.org/?v=2.6.2 By: Laurie http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-345483 Laurie Tue, 06 May 2008 01:23:53 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-345483 "Organon voluntarily withdrew the drug in March 2001" How to you call a drug "excellent" when even the manufacturer removed it from the market? In an intubation situation I would take the lower risk of bronchospasm over speed.No reason to intubate someone you can't get air into after your done. “Organon voluntarily withdrew the drug in March 2001″

How to you call a drug “excellent” when even the manufacturer removed it from the market? In an intubation situation I would take the lower risk of bronchospasm over speed.No reason to intubate someone you can’t get air into after your done.

]]> By: Melonie Davis http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-345418 Melonie Davis Tue, 06 May 2008 01:01:57 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-345418 You will always have deaths when new products come into the market, especially for intubation. Bronchospasms occur in a certain portion of the population when administered NMBA's I sold this product and it was an excellent drug, when used on the appropriate patients at the right dose. The risks must outweigh the benefits, and I believe that is what you must look at. There are plenty of physicians that are ignorant and don't know what doses, etc these medications should be dosed at. Remember, the only reason that there are any advances in medicine, is because the PHARMACEUTICAL companies take all the years and risk of marketing, research, development, legal regulations, etc and decide to try and make a go of it. The Government does not discover any new medications, and the insurance companies certainly do not. Organon is like any other company, taking on tremendous risk and trying to make new medications that help people, and be profitable. You will always have deaths when new products come into the market, especially for intubation. Bronchospasms occur in a certain portion of the population when administered NMBA’s
I sold this product and it was an excellent drug, when used on the appropriate patients at the right dose. The risks must outweigh the benefits, and I believe that is what you must look at. There are plenty of physicians that are ignorant and don’t know what doses, etc these medications should be dosed at.

Remember, the only reason that there are any advances in medicine, is because the PHARMACEUTICAL companies take all the years and risk of marketing, research, development, legal regulations, etc and decide to try and make a go of it. The Government does not discover any new medications, and the insurance companies certainly do not. Organon is like any other company, taking on tremendous risk and trying to make new medications that help people, and be profitable.

]]> By: Concerned http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-290313 Concerned Thu, 17 Apr 2008 15:50:10 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-290313 It's amazing to me that this story has not gained much interest. Perhaps because it simply reinforces "business as usual" for these pharma companies. I, for one, cannot believe the levels that these companies will stoop to in order to generate revenues. You put something on the market that has the potential to harm patients and you fail to warn the practitioners of the problem. Why? Because you don't want to have anything impact the market in a negative way. I just read the same thing about the fen/phen disaster. The marketer in charge didn't want anything to get out about Pulmonary Hypertension in young women because the market for the drug could be cut by 50%. So she would rather continue to have young women take a combo of drugs so that she can make a lot of money than risk her market share. With Raplon, the guy in charge of the US at Organon was reported to have touted the drug as a major advance at the launch, all the while not revealing anything about the dirty little secret. Then what happens? The docs that are concerned get terminated! So much for caring about patients. Responsible, ethical professionals bring forth issues that they are concerned about and the pharma companies get rid of them. I've heard about this happening so many times that it cuases one to wonder. Will ethics and morals ever have a place in American business, specifically drugs, tobacco and oil? Rake the public over the coals at your whim! You'll never have to pay for your misdeeds. That's what the big execs think and until somebody somewhere takes them to task, they'll continue to do it. It’s amazing to me that this story has not gained much interest. Perhaps because it simply reinforces “business as usual” for these pharma companies. I, for one, cannot believe the levels that these companies will stoop to in order to generate revenues. You put something on the market that has the potential to harm patients and you fail to warn the practitioners of the problem. Why? Because you don’t want to have anything impact the market in a negative way. I just read the same thing about the fen/phen disaster. The marketer in charge didn’t want anything to get out about Pulmonary Hypertension in young women because the market for the drug could be cut by 50%. So she would rather continue to have young women take a combo of drugs so that she can make a lot of money than risk her market share.

With Raplon, the guy in charge of the US at Organon was reported to have touted the drug as a major advance at the launch, all the while not revealing anything about the dirty little secret. Then what happens? The docs that are concerned get terminated! So much for caring about patients. Responsible, ethical professionals bring forth issues that they are concerned about and the pharma companies get rid of them. I’ve heard about this happening so many times that it cuases one to wonder. Will ethics and morals ever have a place in American business, specifically drugs, tobacco and oil? Rake the public over the coals at your whim! You’ll never have to pay for your misdeeds. That’s what the big execs think and until somebody somewhere takes them to task, they’ll continue to do it.

]]> By: Farmanux News http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-286445 Farmanux News Tue, 15 Apr 2008 22:04:15 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-286445 [...] you ask? Ed has the scoop! Read [...] [...] you ask? Ed has the scoop! Read [...]

]]> By: Farmanux News http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-286441 Farmanux News Tue, 15 Apr 2008 22:00:23 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-286441 [...] you ask? Ed has the scoop! Source: [...] [...] you ask? Ed has the scoop! Source: [...]

]]> By: Dan http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-285697 Dan Tue, 15 Apr 2008 16:37:30 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-285697 To speculate- Schering purchases organon to deny wrongdoing associated with that particular company by Schering. Seems this has occured in the past. To speculate- Schering purchases organon to deny wrongdoing associated with that particular company by Schering. Seems this has occured in the past.

]]> By: FBP http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-285652 FBP Tue, 15 Apr 2008 16:11:52 +0000 http://www.pharmalot.com/2008/04/organon-covered-up-raplon-side-effects/#comment-285652 It indeed appears that the woes are continuing to mount for Schering-Plough. What is very puzzling is why in the world they would purchase Organon? They certainly should have known about these allegations, given that one of their own current employees headed Organon when these misdeeds allegedly took place. Did they not perform due diligence? Did they not ask the former head of Organon in the US about his knowledge of these activities? This is very curious. And why would a company with recent problems of their own that they had just settled take on more problems by buying Organon. This appears to be either a bad business deal or a lack of concern regarding these allegations. More and more, we're seeing that companies apparently have very little regard for patient safety. It certainlt seems like this happened in this case. Were they so bent on making money that they failed to bring this information forward? If so, this is absolutely horrible. Hundreds of patients may have suffered through an unnecessary ordeal because of this. It seems likely that more trouble is in the wind for Schering-Plough. It indeed appears that the woes are continuing to mount for Schering-Plough. What is very puzzling is why in the world they would purchase Organon? They certainly should have known about these allegations, given that one of their own current employees headed Organon when these misdeeds allegedly took place. Did they not perform due diligence? Did they not ask the former head of Organon in the US about his knowledge of these activities? This is very curious. And why would a company with recent problems of their own that they had just settled take on more problems by buying Organon. This appears to be either a bad business deal or a lack of concern regarding these allegations.

More and more, we’re seeing that companies apparently have very little regard for patient safety. It certainlt seems like this happened in this case. Were they so bent on making money that they failed to bring this information forward? If so, this is absolutely horrible. Hundreds of patients may have suffered through an unnecessary ordeal because of this. It seems likely that more trouble is in the wind for Schering-Plough.

]]>